These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 7840829
21. p53 mutation in plasma DNA and its prognostic value in breast cancer patients. Shao ZM, Wu J, Shen ZZ, Nguyen M. Clin Cancer Res; 2001 Aug; 7(8):2222-7. PubMed ID: 11489795 [Abstract] [Full Text] [Related]
22. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses. Tada M, Iggo RD, Waridel F, Nozaki M, Matsumoto R, Sawamura Y, Shinohe Y, Ikeda J, Abe H. Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587 [Abstract] [Full Text] [Related]
23. Genetic analysis of DNA microsatellite loci in salivary gland tumours: comparison with immunohistochemical detection of hMSH2 and p53 proteins. Ohki K, Kumamoto H, Ichinohasama R, Suzuki M, Yamaguchi T, Echigo S, Motegi K, Ooya K. Int J Oral Maxillofac Surg; 2001 Dec; 30(6):538-44. PubMed ID: 11829237 [Abstract] [Full Text] [Related]
24. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Prosser J, Thompson AM, Cranston G, Evans HJ. Oncogene; 1990 Oct; 5(10):1573-9. PubMed ID: 2250913 [Abstract] [Full Text] [Related]
26. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Ohue M, Tomita N, Monden T, Fujita M, Fukunaga M, Takami K, Yana I, Ohnishi T, Enomoto T, Inoue M. Cancer Res; 1994 Sep 01; 54(17):4798-804. PubMed ID: 8062281 [Abstract] [Full Text] [Related]
28. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU. Cancer Res; 1992 Dec 01; 52(23):6716-21. PubMed ID: 1358438 [Abstract] [Full Text] [Related]
32. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas. Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ. Clin Cancer Res; 2002 May 01; 8(5):1117-24. PubMed ID: 12006527 [Abstract] [Full Text] [Related]
33. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Williams AC, Browne SJ, Yeudal WA, Paterson IC, Marshall CJ, Lane DP, Paraskeva C. Oncogene; 1993 Nov 01; 8(11):3063-72. PubMed ID: 8414507 [Abstract] [Full Text] [Related]
35. [Tumor suppressor gene p53--function and significance in gastroenterology]. Schoppmeyer K, Keim V, Mössner J. Z Gastroenterol; 1997 Jun 01; 35(6):491-509. PubMed ID: 9281241 [Abstract] [Full Text] [Related]
36. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas. Varley JM, Brammar WJ, Lane DP, Swallow JE, Dolan C, Walker RA. Oncogene; 1991 Mar 01; 6(3):413-21. PubMed ID: 2011397 [Abstract] [Full Text] [Related]
37. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K. Oncogene; 1991 Aug 01; 6(8):1313-8. PubMed ID: 1886708 [Abstract] [Full Text] [Related]
38. Clinical implications of the p53 gene. Sidransky D, Hollstein M. Annu Rev Med; 1996 Aug 01; 47():285-301. PubMed ID: 8712782 [Abstract] [Full Text] [Related]
39. Prognostic relevance of transforming genes. Schlegel U, Neumann J, Kindermann D, Wolf HK, Baumann A, Forster F, Fimmers R. Recent Results Cancer Res; 1994 Aug 01; 135():43-53. PubMed ID: 8047696 [No Abstract] [Full Text] [Related]
40. Early genetic changes involved in low-grade astrocytic tumor development. Arjona D, Rey JA, Taylor SM. Curr Mol Med; 2006 Sep 01; 6(6):645-50. PubMed ID: 17022734 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]